RPM posts 7.4% sales growth; EPS flat as higher SG&A, interest and restructuring weigh

Quick take - RPM International Inc. (NYSE: RPM)

Here's what's happening inside the company from the Form 10‑Q for the quarter ended August 31, 2025. Straightforward summary, positives and negatives from the income statement, followed by the key statistics you need to scan.

High‑level view
RPM posted revenue growth driven by acquisitions and organic strength in CPG and PCG, while margin pressure from materials inflation, higher SG&A and rising interest expense constrained bottom‑line leverage. Net income and EPS were essentially flat year‑over‑year.

Income‑statement positives
* Strong top‑line: consolidated net sales rose to $2,113,743 (Q1 ended Aug 31, 2025) from $1,968,789 a year earlier (+7.4%).
* Gross profit increased to $893,216 vs $836,673, with gross margin roughly stable (management reports ~42.3%).
* Investment gains contributed favorably: investment (income), net was a gain of $13,404 (benefit to income).
* Operating cash flow remains healthy: cash provided by operating activities $237,510.

Income‑statement negatives
* SG&A jumped to $573,534 from $526,146 - SG&A increased to 27.1% of sales, driven by acquisitions, merit increases, marketing and healthcare costs.
* Restructuring and one‑time charges persist: MAP 2025 restructuring expense was $8,814 this quarter (vs $7,202 last year) and management expects further project costs.
* Interest expense rose to $29,326 (from $24,434) reducing pre‑tax earnings.
* Effective tax rate up to 23.6% (from 21.3%), reducing after‑tax income.
* Net income essentially flat: consolidated net income $227,840 vs $228,554 last year; diluted EPS unchanged at $1.77.

Key facts & statistics (pick‑up points)
* Net sales (consolidated): $2,113,743 (Q1 FY2026) vs $1,968,789 (Q1 FY2025).
* Segment sales (Q1 FY2026): CPG $881,446; PCG $538,478; Consumer $693,819.
* Gross profit: $893,216; Cost of sales: $1,220,527.
* SG&A expense: $573,534 (up ~$47.4M YoY).
* Restructuring expense (MAP 2025): $8,814 for the quarter; cumulative to date costs $75,461 with total expected $89,317.
* Interest expense: $29,326. Investment (income), net: $(13,404) (gain). Other (income), net: $(3,101).
* Income before taxes: $298,047. Provision for income taxes: $70,207. Net income: $227,840.
* EPS (diluted): $1.77 (unchanged YoY). Basic EPS: $1.78.
* Cash and cash equivalents: $297,075 (end of period). Operating cash flow: $237,510.
* Cash used in investing: $(182,391) (includes acquisitions of $115,695 this quarter).
* Cash used in financing: $(64,135). Share repurchases this quarter: 146,191 shares for ~$17.5M (avg ~$119.70); repurchase capacity remaining ~$174.8M.
* Balance sheet snapshot: Total assets $7,944,545; total equity $3,056,594.
* Receivables (net): $1,472,993. Inventories: $1,068,183.
* Goodwill: $1,657,612. Long‑term debt (less current maturities): $2,661,990 (carrying value of long‑term debt incl. current portion $2,669,424; fair value cited at $2,571,528).
* Liquidity: available liquidity (cash + committed credit) ~$933.4M. Net leverage ratio (reported): 1.87x (in covenant compliance).
* Legal/contingent items: Court judgment entered at $110.8M (district court) plus interest and fees; RPM estimates a possible outcome range of ~$0.5M to ~$152.3M and has accrued at the low end. EPA proposed penalty revised to ~$1.4M (disputed).

What to watch next
* Margin recovery vs. inflation and temporary MAP 2025 inefficiencies - can pricing and MAP savings offset material cost inflation?
* SG&A trend and integration costs from acquisitions - will SG&A leverage improve as acquired businesses are integrated?
* Interest cost trajectory and debt levels given active M&A and acquisition financing.
* Resolution of major litigation (potentially material range) and EPA matter - outcome could move reserves and earnings.
* Execution on remaining MAP 2025 items and whether expected incremental savings materialize.

Bottom line: RPM shows durable sales growth and strong operating cash generation, but higher SG&A, sustained restructuring costs, rising interest expense and unresolved legal contingencies limit near‑term EPS upside. The company remains well‑capitalized with sizable liquidity and an active buyback program; investors should track margin trends and legal outcomes.